View
12
Download
1
Category
Preview:
Citation preview
저 시 2.0 한민
는 아래 조건 르는 경 에 한하여 게
l 저 물 복제, 포, 전송, 전시, 공연 송할 수 습니다.
l 차적 저 물 성할 수 습니다.
l 저 물 리 목적 할 수 습니다.
다 과 같 조건 라야 합니다:
l 하는, 저 물 나 포 경 , 저 물에 적 된 허락조건 명확하게 나타내어야 합니다.
l 저 터 허가를 면 러한 조건들 적 되지 않습니다.
저 에 른 리는 내 에 하여 향 지 않습니다.
것 허락규약(Legal Code) 해하 쉽게 약한 것 니다.
Disclaimer
저 시. 하는 원저 를 시하여야 합니다.
1
Wnt Inhibitory Factor (WIF)-1 Promotes
Melanogenesis in Normal Human
Melanocytes
by
Hye Ran Kim
Major in Molecular Medicine
Department of Biomedical Sciences
The Graduate School, Ajou University
2
Wnt Inhibitory Factor (WIF)-1 Promotes
Melanogenesis in Normal Human Melanocytes
by
Hye Ran Kim
A Dissertation Submitted to The Graduate School of Ajou University
in Partial Fulfillment of the Requirements for the Degree of
MASTER OF BIOMEDICAL SCIENCES
Supervised by
Hee Young Kang, M.D., Ph.D.
Major in Molecular Medicine
Department of Biomedical Sciences
The Graduate School, Ajou University
August, 2011
3
4
감사
본 논 할 지 심 양면 도움 주시고 지도 조언 아끼지
않 셨 지도 이신 강희 님께 감사를 드립니다. 또한 좋
연구를 할 있도 많 조언과 격 를 주신 태 님과 강엽
님께도 감사 마 합니다.
그리고 연구 간 동안 도움 주신 피부과학 실 모든 생님들과 이
사님, 용 사님, 경이, 규 이, 조직 포 염색과 분 도 주신
생님께 감사 드립니다. 심 힘들 곁에 힘이 어 든든한
구 사, 사님과 연주 사, 권민 사 그리고 항상 격
해 주신 생님, 이명애 님께도 감사 드립니다.
언 나 아낌 없는 사랑 지원해 주시고 믿어주신 부모님과 큰엄마, 다른
가족들에게도 감사 마 합니다.
2011 6 월
자씀
5
- ABSTRACT -
Wnt Inhibitory Factor (WIF)-1 Promotes Melanogenesis in
Human Melanocytes
Background: Wnt inhibitory factor-1 (WIF-1) acts as a suppressor of Wnt antagonists.
There is no study available on melanogenesis effect of human melanocytes.
Objectives: In this study, we investigated the expression of WIF-1 in human melanocytes
and the effects of WIF-1 on melanogenesis.
Method: To determinutese whether WIF-1 is expressed in human melanocytes, we used
immunocytochemistry, immunhistochemistry, western blot analysis and reverse transcription
polymerase chain reaction. The cell proliferation was measured using the coulter counter.
The effects on pigmentation were investigated with measurement of melanin contents,
tyrosinase activity and its expression.
Result: WIF-1 was expressed in melanocytes. WIF-1 inhibited proliferation of human
melanocytes in a dose-dependent manner. WIF-1 also appeared to stimulate the melanin
synthesis of human melanocytes. This increase in pigmentation was due to stimulation of the
tyrosinase activity and increased expression of MITF and tyrosinase.
Conclusion: We demonstrated that WIF-1 was expressed in human melanocytes. Our
findings suggest that WIF-1 may play a role in melanogenesis.
Key Words: melanocyte, melanogenesis, WIF-1, pigmentation, Wnt antagonist
6
TABLE OF CONTENTS
ABSTRACT --------------------------------------------------------------------------------------------- 5
TABLE OF CONTENTS ------------------------------------------------------------------------------ 6
LIST OF FIGURES ------------------------------------------------------------------------------------- 8
LIST OF TABLES -------------------------------------------------------------------------------------- 9
I. INTRODUCTION ----------------------------------------------------------------------------------- 10
A. Human melanocyte development and pigmentati on ------------------------------------ 10
B. Wnt signaling pathway ----------------------------------------------------------------------- 12
C. The Wnt family -------------------------------------------------------------------------------- 14
D. The Wnt antagonist ---------------------------------------------------------------------------- 15
E. Melanocyte and Wnt signaling --------------------------------------------------------------- 18
II. MATERIALS AND METHODS ----------------------------------------------------------------- 19
A. Human melanocyte culture ------------------------------------------------------------------ 19
B. B16 melanoma cell lines culture ------------------------------------------------------------ 19
C. Human fibroblast culture --------------------------------------------------------------------- 20
D. Human keratinocyte culture ----------------------------------------------------------------- 20
E. Cell growth assay ------------------------------------------------------------------------------ 20
F. Melanin content determinutesation --------------------------------------------------------- 12
G. Tyrosinase activity assay --------------------------------------------------------------------- 21
H. Skin organ culture ----------------------------------------------------------------------------- 21
I. Pigmentation assay in cultured skin --------------------------------------------------------- 21
J. Immunocytochemistry ------------------------------------------------------------------------ 22
7
K. Western blottiong ----------------------------------------------------------------------------- 23
L. WIF-1 transfection ---------------------------------------------------------------------------- 23
M. Reverse transcriptase-polymerase chain reaction (RT-PCR) -------------------------- 24
N. Statistical analysis ----------------------------------------------------------------------------- 24
III. RESULTS ------------------------------------------------------------------------------------------- 25
A. WIF-1 is expressed in human melanocytes, fibroblasts and keratinocytes ---------- 25
B. WIF-1 increases pigmentation of cultured human skin --------------------------------- 27
C. WIF-1 treatment enhances pigmentation in B16 melanoma cells --------------------- 29
D. WIF-1 treatment enhances pigmentation in human melanocytes ---------------------- 32
E. WIF-1 transfection induces pigmentation in B16 melanoma cells -------------------- 35
F. WIF-1 transfection induces pigmentation in human melanocytes --------------------- 38
IV. DISCUSSION -------------------------------------------------------------------------------------- 41
V. CONCLUSION ------------------------------------------------------------------------------------- 42
REFERENCES ----------------------------------------------------------------------------------------- 43
국 요약 ------------------------------------------------------------------------------------------------ 49
8
LIST OF FIGURES
Fig. 1. Melanogenesis --------------------------------------------------------------------------------- 11
Fig. 2. Wnt signaling pathways ---------------------------------------------------------------------- 13
Fig. 3. WIF-1 is expressed in human melanocytes, fibroblasts and keratinocytes------------- 26
Fig. 4. WIF-1 increases pigmentation of cultured human skin ---------------------------------- 28
Fig. 5. WIF-1 treatment enhances pigmentation in B16 melanoma cells ---------------------- 30
Fig. 6. WIF-1 treatment enhances pigmentation in human melanocytes ---------------------- 33
Fig. 7. WIF-1 transfection induces pigmentation in B16 melanoma cells --------------------- 36
Fig. 8. WIF-1 transfection induces pigmentation in human melanocytes --------------------- 39
9
LIST OF TABLES
Table 1. Wnt antagonist family molecules --------------------------------------------------------- 17
Table 2. Effects of WIF-1 on proliferation, melanin contents and tyrosinase activity of
B16 melanoma cells -------------------------------------------------------------------------- 31
Table 3. Effects of WIF-1 on proliferation, melanin contents and tyrosinase activity of
human melanocytes -------------------------------------------------------------------------- 34
Table 4. Effects of WIF-1 transfection on proliferation, melanin contents and tyrosinase
activity of B16 melanoma cells ------------------------------------------------------------ 37
Table 5 . Effects of WIF-1 transfection on proliferation, melanin contents and tyrosinase
activity of human melanocytes ------------------------------------------------------------- 40
10
I. INTRODUCTION
A. Human melanocyte development and pigmentation
Human skin is made up of two main layers, the epidermis, which is described as a
stratified squamous epithelium mainly consisting of keratinocytes, and the dermis, an
underlying layer of vascularized connective tissue. Human melanocytes reside at the junction
of the dermis and the epidermis. Mature human melanocytes form long dendritic processes
that ramify among the neighboring keratinocytes. Human melanocytes are well known for
their role in skin pigmentation and their ability to produce and distribute melanin.
The human melanocyte transform the peptide tyrosinase into two different forms of
melanin, which then is spread throughout the dermal cells and the keratinocytes via
melanosomes to darken tissue. Figure 1 shows the chemical metabolism that occurs intra-
cellulary to produce melanin from the precursors phenylalanine and tyrosine. Eumelanin is
metabolized from DHICA and produces a brown color in hair in its intact form. Pheomelanin
is metabolized from 5,6-indolequione, which produces a red color in hair in its intact form.
From these two slightly different forms of pigment in various degrees of structural integrity
come all the differing shades of Caucasian hair (Prota, 2000). In addition to coloration,
melanin pigmentation in the skin also provides photoprotection from UV radiation to the
skin. However, the melanocytes themselves are not immune from radiation damage.
11
Fig. 1. Melanogenesis. L-Phenylalanine is metabolized in the presence of three major
enzymes, phenylalanine hydroxylase, tyrosine hydroxylase isoform I and tyrosinase, to
eumelanin and phaeomelanin. Alpha MSH, α-melanocyte stimulating hormone; UV,
ultraviolet. (Langan et al., 2010)
12
B. Wnt signaling pathway
Wnt proteins constitute a large family of 19 secreted glycoproteins that regulate many
aspects of cell physiology, including proliferation, migration and differentiation in
embryogenesis and adult tissue homeostasis (Cadigan and Nusse, 1997). The signaling
pathway mediated by Wingless-type (Wnt) proteins is highly conserved in evolution. This
pathway, initially described in Drosophila as critical for embryogenesis, has since been
shown to regulate cell fate decisions, cell proliferation, morphology, migration, apoptosis,
differentiation and stem cell self-renewal.
In the Wnt signaling pathway, ß-catenin is a key mediator. In the absence of Wnt
signals, cytosolic ß-catenin is recruited to a multi-protein ‘‘destruction complex’’ that
consists of casein kinase 1, adenomatous polyposis coli, Axin, and glycogen synthase kinase-
3ß (GSK-3ß) (Langan et al., 2010). In the resting state, ß-catenin is phosphorylated by GSK-
3ß and is subsequently targeted for degradation via the ubiquitin proteosome pathway (Batra
et al., 2006). Binding of Wnt ligands to their Frizzled receptors triggers the Wnt/ß-catenin
pathway, also termed the canonical Wnt pathway, through phosphorylation and increased
activity of Dishevelled (Dvl) (Itoh et al., 1998). Dvl activity alters the composition of the
‘‘destruction complex’’ with a net result of reduction. ß-catenin subsequently translocates to
the nucleus and interacts with TCF/LEF transcription factors (Behrens and Lustig, 2004;
Langan et al., 2010). TCF target genes include cyclin D1, VEGF, and Survivin, among
others (Shtutman et al., 1999). ß-catenin independent Wnt signaling, also termed non-
canonical signaling, may proceed through calcium flux, G proteins, and JNK (Veeman et al.,
2003).
13
Fig. 2. Wnt signaling pathways. In the absence of Wnt ligand, the "destruction complex"
composed of the core proteins Axin, adenomatous polyposis coli (APC), and glycogen
synthase kinase-3 (GSK3) rapidly phosphorylates (P) cytosolic ß-catenin, targeting it for
subsequent ubiquitination (Ub) and proteasome-mediated destruction. Binding of Wnt to
Frizzled (Fzd) and low-density lipoprotein receptor-related protein 5/6 (LRP5/6) activates
the cytosolic protein Dishevelled (DVL), leading to inhibition of the destruction complex.
The resulting accumulated ß-catenin can then translocate to the nucleus to activate Wnt-
responsive target genes regulated by TCF and LEF family transcription factors, leading to
various cellular effects. Activation of the small GTPases Rho and Rac can result in
cytoskeletal rearrangements that affect cellular motility upon Wnt stimulation. Binding of
Wnt isoforms to either Fzd or receptors such as receptor tyrosine kinase-like orphan receptor
2 (Ror2, a receptor for Wnt-5a) can trigger ß-catenin-independent downstream sgnaling
14
events, including the inhibition of Wnt/ ß-catenin signaling. The mechanisms underlying ß-
catenin-independent Wnt signaling are not well defined and may be largely determinutese by
cellular context. The secreted inhibitor Dickkopf (DKK) can antagonize Wnt signaling by
competitively binding to LRP5/6. Secreted Fzd-related proteins (SFRPs) and Wnt inhibitory
factor (WIF) are thought to antagonize Wnt signaling by sequestering Wnt ligand in the
extracellular space (Chien et al., 2009).
C. The Wnt family
The Wnt gene family in mammalian systems is now known to consist of almost 20
members which generally fall into two classes: classical Wnts (Wnt1, Wnt3a, Wnt8, Wnt8b)
activate signaling through the canonical pathway and nonclassical Wnts (Wnt4, Wnt5a,
Wnt11) specifically activate noncanonical pathways. Wnt proteins are cysteine-rich secreted
glycoproteins and on the cell surface bind to co-receptors: Fz proteins which are members of
the frizzled (Fz) family of seven transmembrane receptors, and LRP-5 or LRP-6 which of
members of the family of low-density lipoprotein receptor-related protein (LRP) single
transmembrane receptors. In mammalian cells, there are 10 known Fz receptors which
contain seven transmembrane domains, an extracellular cysteine-rich domain (CRD) which
specifically binds to Wnt ligands, and an intracellular carboxyl tail. It has been difficult to
test which Wnts bind to which Fz receptors since Wnt proteins are hard to be purified.
15
D. The Wnt antagonist
According to the mechanisms of action, naturally endogenous Wnt antagonists can be
divided into two classes. The first class includes the secreted Frizzled-related protein (sFRP)
family, WIF-1, and Cerberus. These molecules exert inhibition through direct binding to Wnt
proteins. The second class including the Dickkof (DKK) family inhibits Wnt signaling by
binding to the Frizzled (Fz) coreceptor LRP5/LRP6 (Kawano and Kypta, 2003).
sFRPs are antagonists that directly bind to Wnts. They were initially given several names,
reflecting their simultaneous discovery by different approaches (Jones and Jomary, 2002).
There are presently eight known members of the family. A unifying nomenclature now
exists for five of these (sFRP1 to sFRP5) (Table 1.), although sFRP3 is still better known as
FrzB (for Frizzled motif associated with bone development). On the basis of sequence
homology, sFRP1, sFRP2, and sFRP5 form a subgroup as do sFRP3 and sFRP4, which are
quite distantly related to the other sFRPs. Sizzled, Sizzled2 and Crescent form a third
subgroup, but these have not been identified in mammals. There are conflicting reports on
the ability of Sizzled to inhibit Wnt signaling (Collavin and Kirschner, 2003; Veeman et al.,
2003). With one exception (Collavin and Kirschner, 2003), sFRPs (and the other Wnt
antagonists) have not been found in invertebrates. Despite this, many of them have been
demonstrated to inhibit the activity of the Drosophila Wnt homologue Wingless (Wg).
WIF is an evolutionary conserved protein of 379 aminuteso acid residues and
constitutes another member of the secretary Wnt modulators that directly bind to Wnt
proteins similar to sFRPs. WIF-1 was first identified as an expressed sequence tag from
human retina with highly conserved orthologues in xenopus and zebrafish (Collavin and
Kirschner, 2003).
16
The phenotype induced by injection of RNA encoding WIF-1 into early xenopus
embryos, namely induction of a partial secondary axis and abnormal somitogenesis,
suggested it played a role in the Wnt signaling pathway (Hsieh et al., 1999).
Cerberus is another Wnt antagonist that belongs to the same class as WIF-1 and sFRPs.
It was isolated from Xenopus as an abundant organizer-specific molecule (Bouwmeester et
al., 1996). It is expressed in the anterior endoderm including the Spemann's organizer and
has the unique property of inducing an ectopic head without trunk formation. Trunk
formation relies on Nodal and Wnt signaling, whereas head induction requires inhibition of
Wnt and bone morphogenetic protein (BMP) signaling. Cerberus, as a multivalent growth-
factor antagonist, inhibits all three signaling pathways, which leads to simultaneous head
formation and trunk inhibition.
The Dkk family comprises four members (Dkk-1 to Dkk-4) and a unique Dkk-3-related
protein named Soggy (Sgy). Dkks contain two characteristic cysteine-rich domains (Cys-1
and Cys-2) separated by a linker region of variable length (Glinka et al., 1998; Krupnik et al.,
1999). Cys-2, in particular, is highly conserved among all members of the family and
contains 10 conserved cysteine residues; this is similar to the proteins of the colipase family,
with which Dkk proteins share weak sequence similarity (Aravind and Koonin, 1998;
Krupnik et al., 1999). Detailed protein sequence and structural analysis suggested that Dkks
and colipase have the same disulfide-bonding pattern and a similar fold. Colipases are
essential for lipid hydrolysis by pancreatic lipases and interact with lipid (van Tilbeurgh et al.,
1999). It is not known whether the structural similarity between colipases and Dkks implies a
common function such as lipid interaction.
17
Table 1. Wnt antagonist family molecules (Kawano and Kypta, 2003).
18
E. Melanocyte and Wnt signaling
Melanocytes arise from neural crest cells that migrate from the lateral edge of the neural
plate to become a variety of cells including glial cells, smooth muscle cells, and neurons
(Dorsky et al., 1998). Wnt signaling plays a critical role in the development of the neural
crest, specifically Wnt1 and Wnt3A (Dorsky et al., 1998; Dunn et al., 2000). Canonical Wnt
signaling including Wnts such as Wnt6 (Schmidt et al., 2008) and Wnt8 is required both for
the induction of the neural crest, and for its expansion, and controls the expression of a
variety of key proteins including Slug and Snail (LaBonne and Bronner-Fraser, 1998; Sakai
et al., 2005). Wnt1 and Wnt3A also promote the development of neural crest cells into
pigment cells. When cells are depleted of these two proteins, they become neuronal rather
than pigmented cells (Dorsky et al., 1998). Wnt1 signals to melanoblasts in a paracrine
manner to increase melanocyte numbers, while Wnt3A and b-catenin can specify neural crest
cells to become melanocytes (Dunn et al., 2005). In mice, melanoblasts are concentrated in
the hair follicles where they differentiate into melanocytes, whereas in humans, melanocytes
interact with keratinocytes in the epidermis. This is controlled by DKK1 (Yamaguchi et al.,
2008) and Wnt signaling via Wnts 1, 3A, and 4 (Saitoh et al., 1998).
Wnt inhibitory factor-1 (WIF-1) acts as a suppressor of Wnt antagonists. However,
there is no study available on melanogenesis effect of human melanocytes. In this study, we
investigated the expression of WIF-1 in human melanocytes and the effects of WIF-1 on
melanogenesis.
19
II. MATERIALS AND METHODS
A. Human melanocyte culture
Normal human melanocytes were derived from the adult foreskin and maintained in a
F12 medium supplemented with 10% heat-inactivated fetal bovine serum (FBS), 1%
antibiotic/antimycotic solution (all from Gibco-BRL, Grand Island, NY, U.S.A.), 24 μg/, 3-
isobutyl-1-methylxanthine, 80 nM 12-O-tetradecanoyl phorbor-13-acetate, 1.2 ng/㎖ basic
fibroblast growth factor and 0.1 μg/㎖ cholera toxin (all from Sigma Chemical Co., St.
Louis, MO, U.S.A.). For experiments, melanocytes at passage 2 or 3 were used and
maintained in MCDB-153 containing 4% heat-inactivated fetal bovine serum (FBS), 0.6
ng/㎖ basic fibroblast growth factor, 5 μg/㎖ insulin, 1 μg/㎖ vitaminutes E, and 1
μg/㎖ transferrin (all from Sigma Chemical Co., St. Louis, MO, U.S.A.).
B. B16 melanoma cell lines culture
B16 melanoma cells was added in RPMI1640 (all from Gibco-BRL, Grand Island, NY,
U.S.A.) media containing 10% fetal bovine serum (FBS) and 10% penicillin-streptomycin
and incubated at 37°C, 5% co2. Media were changed every 3 days.
20
C. Human fibroblast culture
Normal human fibroblast were derived from the adult foreskin and maintained in a
RPMI1640 medium supplemented with 10% heat-inactivated fetal bovine serum (FBS), 1%
antibiotic/antimycotic solution (all from Gibco-BRL, Grand Island, NY, U.S.A.). For
experiments, fibroblast at passage 2 or 3 were used and maintained in RPMI1640 medium
supplemented with 10% heat-inactivated fetal bovine serum and 1% antibiotic/antimycotic
solution (all from Gibco-BRL, Grand Island, NY, U.S.A.).
D. Human keratinocyte culture
Normal human keratinocyte were derived from the adult foreskin and maintained in a
Defined K-SFM medium supplemented with 5% heat-inactivated fetal bovine serum (FBS)
(all from Gibco-BRL, Grand Island, NY, U.S.A.). For experiments, fibroblast at passage 2
or 3 were used and maintained in RPMI1640 medium supplemented with 10% heat-
inactivated fetal bovine serum and 1% antibiotic/antimycotic solution (all from Gibco-BRL,
Grand Island, NY, U.S.A.).
E. Cell growth assay
Melanocytes or B16 melanoma cells line were plated at a density of 2×105 cells/㎠ in
60㎜ culture dishes. After 1 day of culture, the medium was changed to fresh medium
containing different concentrations of 0.5~5 ㎍/㎖ WIF-1 (R&D systems Inc.,
Minutesneapolis, MN, U.S.A.). After 5 days or 3 days of culture, the cells were counted with
Coulter counter (Coulter Electronics, Hialcah, FL). The cell cytotoxicity was examinutesed
using trypan blue exclusion assay.
21
F. Melanin content determinutesation
Melanocytes or B16 melanoma cells line were treated with different concentrations of
the 0.5-5 ㎍/㎖ WIF-1 for 5 days or 3 days. Melanin content was measured according to the
method of Tsuboi et al (Tsuboi et al., 1998). With a slight modification. pellets of 2X105
cells were solubilized in 1 M NaOH and the optical densities were measured at 490㎚ using
an enzyme-linked immunosorbent assay reader. The absorbance was compared with a
standard curve of synthetic melanin (Sigma Chemical Co., St. Louis, MO, U.S.A.).
G. Tyrosinase activity assay
Dopa oxidase activity was determinutesed by the method described by Tomita et al
(Tomita et al., 1992). With slight modification. Cells were solubilized with 1% Triton-X and
10 mmol/1 L-DOPA (Sigma Chemical Co., St. Louis, MO, U.S.A.). Following 90 minutes
incubation at 37 °C, the absorbance was measured at 490 ㎚.
H. Skin organ culture
Skin samples of human breast skin were obtained during breast surgery after receiving
consent and cultured as previously described (Jansen et al., 1998). A sterilized stainless steel
grid was placed on a 35-㎜ culture dish. Dulbecco’s modified Eagle’s minutesimal essential
medium supplemented with 10% FBS and 1% penicillin/streptomycin was filled up to the
stainless steel grid. The skin specimens were placed on the stainless steel grid and cultured in
incubator at 37°C with 5% CO2. The medium was exchanged every 3 days.
22
I. Pigmentation assay in cultured skin
The skin organ was treated with 1 mM WIF-1 (R&D systems Inc., Minutesneapolis,
MN, U.S.A.). After 3 days of culture, the specimens were fixed in 10% formalin, embedded
in paraffin section, and stained with hematoxylin and eosin for light microscope
examinutesation. Melanin pigments were visualized with Fontana–-Masson stain, performed
by usual methods without eosin background stain. The image analysis was evaluated using
Image Pro Plus Version 4.5 (Media Cybertics Co., MD, U.S.A.) and the pigmented area per
epidermal area (PA/EA) was measured.
J. Immunocytochemistry
Melanocytes, Fibroblastes, and keratinocytes (5×103) grown on Lab-Tek chambers
(Nalge Nunc International, Naperville, IL, U.S.A.) were fixed in 4% paraformaldehyde for
30 minutes at room temperature, and permeated in methanol followed by 0.1% Triton X-100
to achieve a nuclear permeance. Slides were placed in methanol containing 0.3% hydrogen
peroxide for 10 minutes, and the non-specific activity was blocked by normal goat serum for
10 minutes. They were incubated with rabbit polyclonal anti-WIF-1 (abcam, England,
Cambridge, UK) overnight at 4°C at 1:50 dilution. Biotinylated antibody against both rabbit
(Dako, Carpinteria, CA, U.S.A.) was incubated for 20 minutesutes at room temperature. The
substrate chromogen 3-aminuteso-9-ethyl-carbazol (Biomeda) was applied for 20 minutes.
Negative controls were made by applying normal rabbit serum (Vector Lab., Burlingame,
CA, U.S.A.) before the primary antibody.
23
K. Western blotting
Human melanocytes or B16 melanoma cell line were lysed in RIPA buffer (1% NP-40,
150㎜ NaCl, 10㎜ Tris–-HCl (pH 8.0), 1 mM EDTA) with 10 ㎍/㎖ aprotinin, 1 mM
sodium orthovandate and 100 ㎍/㎖ phenylmethylsulphonylfluoride, and separated with a
10% SDS-PAGE gel. The protein was then transferred onto a polyvinylidenedifluoride
membrane, and the membrane was probed with Tyrosinase, MITF (abcam, England,
Cambridge,UK), α-tubulin (Cell Signaling Boston Massachusetts, U.S.A.) antibodies. After
incubation with horseradish peroxidase-conjugated goat anti-rabbit (Tyrosinase and α-
tubulin, MITF) antibody, the membrane was developed with an enhanced
chemiluminutesescence detection kit (Amersham Int., Little Chalfont, UK).
L. WIF-1 transfection
Melanocytes or B16 melanoma cell line (2x105) were plated in 60㎜ plates 48 hours
before transfection. Cells were then transfected with a full-length WIF-1 construct in
pcDNA3.1 vector (FL) (Cell Signaling Boston Massachusetts, U.S.A.) or with an empty
pcDNA3.1 vector (EV), using Lipofectaminutese 2000 kit (Invitrogen, Carlsbad, CA, U.S.A.)
transfection reagent according to the manufacturer’s protocol. 48 hours after transfection,
cells were collected for western blot analysis.
24
M. Reverse transcriptase-polymerase chain reaction (RT-PCR)
Minutesi kit (Qiagen Inc., Valencia, CA, U.S.A.), and the cDNA was obtained using
SuperScriptTM III reverse transcriptase kit (Invitrogen, Carlsbad, CA, U.S.A.). Expression of
WIF-1 and ß-actin was measured using semiquantitative PCR. The cDNA was subjected to
PCR using accupower PCR premix kit (Bioneer, Daejeon, Korea). The oligonucleotide
primers for PCR were synthesized by bioneer and were as follows WIF-1, forward primer: 5’
– ATG GCA GAT CCA ACC GTC A, reverse primer: 3’ – AGG TTC CAT GTG CAC
CAC A and ß-actin, , forward primer : 5’ – GTG GGG CGC AGG CAC CA , reverse primer:
3’ – CTC CTT AAT GTC ACG CAC GAT TTC PCR amplification was performed with a
GeneAmp_PCR system 2700 (Applied Biosystems, Foster City, CA, U.S.A.) under the
following conditions: WIF-1 40 cycles at 94°C for 30 s (denaturation), 55°C for 30 seconds
(annealing) and 72°C for 45 seconds (elongation). The PCR products were electrophoresed
on 1.8% agarose gels. Each DNA band was visualized by staining with ethidium bromide.
N. Statistical analysis
All data were compared by one-way analysis of variance (ANOVA) (SPSS 12.0; SPSS
Inc., Chicago, U.S.A.). The results were expressed as mean±standard deviation (SD). All p
values were two tailed and p value less than 0.05 was considered to be of statistical
significance.
25
III. RESULTS
A. WIF-1 is expressed in human melanocytes, fibroblasts and keratinocytes
To investigate whether WIF-1 is expressed in cultured human melanocytes, fibroblasts
and keratinocytes, we first performed RT-PCR analysis. The RT-PCR studies indicated that
human melanocytes, fibroblasts and keratinocytes express WIF-1 mRNA (Fig. 3A.).
Immunocytochemical staining showed immunoreactivity for WIF-1 in human melanocytes,
fibroblasts and keratinocytes (Fig. 3B.).
26
(A)
(B)
Fig. 3. WIF-1 is expressed in human melanocytes, fibroblast and keratinocytes.
Expression of WIF-1 was assessed by RT-PCR (A). The protein expression was detected by
immunocytochemistry (x 400) (B).
27
B. WIF-1 increases pigmentation of cultured human skin
In cultured skin, 5 ㎍/㎖ WIF-1 induced pigmentation (Fig. 4A.). Fontana–Masson
staining showed increased epidermal pigmentation. Image analysis showed a significant
increase in the ratio of PA/EA in WIF-1-treated skin (0.228 ± 0.161), compared to control
skin (0.079 ± 0.056 ) (Fig. 4B.).
28
(A)
(B)
Fig. 4. Effect of WIF-1 on pigmentation in skin organ culture. Fontana–Masson stain. On
culture 3 days, melanin pigments were increased in WIF-1 (5 ㎍/㎖) treated human skin
compared to control (x 200) (A). An Image analysis. The values are the mean of three
independent experiments ± SD (B).
29
C. WIF-1 treatment enhances pigmentation in B16 melanoma cells
To explore the effect of WIF-1 in B16 melanoma cells, B16 melanoma cells were
incubated with different concentrations of WIF-1 (0.5 ㎍/㎖ and 5 ㎍/㎖). The WIF-1
dose-dependently inhibited proliferation of B16 melanoma cells at concentrations between 0
– 5 ㎍/㎖. At a concentration of 0.5 ㎍/㎖ or 5 ㎍/㎖, proliferation was inhibited by 95.8%
± 3.4% or 86.5% ± 7.63% (mean ± SD of DMSO control (100%), n=5) (Fig. 5A.). Next we
examinutesed whether WIF-1 affects pigmentation in B16 melanoma cells. The melanin
content was increased with treatment of WIF-1. WIF-1 (0.5 ㎍/㎖ or 5 ㎍/㎖) increased
melanin content to 117% ± 10.06% or 132.8% ± 17.86% (mean ± SD of DMSO control
(100%), *P <0.001) respectively (Fig. 3B.). Since tyrosinase is known for the key enzyme in
the process of melanin synthesis, dopa-oxidase activity and its expression were
examinutesed to study the action of WIF-1 on melanogenesis. As shown in Figure 5C, the
optical density in the presence of WF-1 (0.5 ㎍/㎖ or 5 ㎍/㎖) had significant increase by
138% ± 26.9% or 170.08% ± 49.6% (mean ± SD of DMSO control (100%), n=5, *P <0.001)
respectively. (Fig. 5C.). These results indicate that WIF-1 regulates tyrosinase and
subsequently induces melanin synthesis in B16 melanoma cells.
30
(A)
(B) (C)
Fig. 5. WIF-1 treatment enhances pigmentation in B16 melanoma cells. WIF-1
inhibits cell growth in B16 melanoma cells. Results were expressed as a percentage
proliferation of the respective controls. Values are the mean ± SD of five independent
experiments. *P < 0.001 using one-way ANOVA (A). Melanin content was
determinutesed by measuring the absorbance at 490 ㎚ of cell lysate. The values indicate
the mean of five independent experiments ± SD. *P < 0.001 using one-way ANOVA (B).
31
The cells were incubated with 10mM L−DOPA for 90 minutes and the absorbance was
measured at 490 ㎚. The values indicate the mean of five independent experiments ± SD.
*P < 0.001 using one-way ANOVA (C).
Table. 2. Effects of WIF-1 on proliferation, melanin contents and tyrosinase activity of
B16 melanoma cells.
32
D. WIF-1 treatment enhances pigmentation in human melanocytes
To explore the effect of WIF-1 in human melanocytes, human melanocytes were incubated
with different concentrations of WIF-1 (0.5㎍/㎖ and 5 ㎍/㎖). The WIF-1 dose-
dependently inhibited proliferation of human melanocytes at concentrations between 0 -
5㎍/㎖. At a concentration of 0.5㎍/㎖ or 5㎍/㎖, cell growth was inhibited by 93.7% ±
4.44% or 75.0% ± 17.68% (mean ± SD of DMSO control (100%), n=5, P <0.001) (Fig. 6A.).
Next we examinutesed whether WIF-1 affects pigmentation in human melanocytes. WIF-1
(0.5 ㎍/㎖ or 5 ㎍/㎖) increased melanin content to 113.3% ± 9.4% or 128.5% ± 20.1%
(mean ± SD of DMSO control (100%), P <0.001) respectively (Fig. 6B.). Dopa-oxidase
activity and its expression were examinutesed. As shown in Figure 6C, the optical density in
the presence of WF-1 (0.5 ㎍/㎖ or 5 ㎍/㎖) had significant increase by 111.6% ± 1.74%
or 151.3% ± 36.29% (mean ± SD of DMSO control (100%), n=5, P <0.001) respectively
(Fig. 6C.). WIF-1 treatment also increased the expression of tyrosinase and MITF. These
result suggesteds suggests that WIF-1 stimulates melanin synthesis through up-regulation of
MITF and tyrosinase expression in human melanocytes (Fig. 6D.).
33
(A) (B)
(C) (D)
Fig. 6. WIF-1 treatment enhanced pigmentation in human melanocytes. WIF-1
decreased cell growth in human melanocytes. Human melanocytes were incubated with
different concentrations of WIF-1 and cell proliferation was measured at 5 days using
the coulter counter. Values are the mean ± SD of five independent experiments. *P <
0.001 using one-way ANOVA (A). Human melanocytes were incubated with different
concentrations of WIF-1 for 5 days. Melanin content was determinutesed by measuring
34
the absorbance at 490 ㎚. The values indicate the mean of five independent experiments
± SD. *P < 0.001 using one-way ANOVA (B). The cells were incubated with 10 mM
L−DOPA for 90 minutes and the absorbance was measured at 490 ㎚. The values indicate
the mean of five independent experiments ± SD. *P < 0.001 using one-way ANOVA (C).
Cell lysates harvested after 5 days culture with MCDB153 medium were analyzed by
western blotting with tyrosinase antibody, MITF antibody (D).
Table. 3. Effects of WIF-1 on proliferation, melanin contents and tyrosinase activity of
human melanocytes.
35
E. WIF-1 transfection induces pigmentation in B16 melanoma cells
To further evaluate the effect of WIF-1 on B16 melanoma cell, we restored WIF-1
expression by gene transfection with a WIF-1-expressing pcDNA3.1 vector (FL). After WIF-
1 transfection for 48 hours, the WIF-1 dose-dependently inhibited proliferation of B16
melanoma cells. WIF-1 transfection also increased melanin content to 157.3% ± 40.6%
(mean ± SD of DMSO control (100%), P <0.001) (Fig. 7B.). WIF-1 transfection increased
expression of MITF and tyrosinase in B16 melanoma cells (Fig. 7C, D.).
36
(A) (B)
(C) (D)
Fig. 7. WIF-1 transfection induces pigmentation in B16 melanoma cells. WIF-1 inhibited
cell growth of B16 melanoma cells. B16 melanoma cells were transfected with WIF-1 vector
and cell proliferation was measured at 3 days using the Coulter counter. Results are
expressed as a percentage of proliferation to the respective controls (A). Melanin content
37
was determinutesed by measuring the absorbance at 490 ㎚ (B). The cells were incubated
with 10 mM DOPA for 90 minutes and the absorbance was measured at 490 ㎚ (C).
Western blot analysis. EV, empty pcDNA3.1 vector; WIF-1, WIF-1 construct in HA vector
(D). (*P < 0.001 using one-way ANOVA. Data are means ± SD.)
Table. 4. Effects of WIF-1 transfection on proliferation, melanin contents and
tyrosinase activity of B16 melanoma cells.
38
F. WIF-1 transfection induces pigmentation in human melanocytes
To further evaluate the effect of WIF-1 on human melanocytes, we restored WIF-1
expression by gene transfection with a WIF-1-expressing pcDNA3.1 vector (FL). After
transfection with WIF-1 for 48 hours, the WIF-1 dose-dependently inhibited proliferation of
human melanocytes. WIF-1 transfection also increased melanin content to 128.1% ± 19.8%
(mean ± SD of DMSO control (100%), *P <0.001 (Fig. 8B.). WIF-1 transfection also
increased expression of MITF and tyrosinase in human melanocytes (Fig. 8C, D.).
39
(A) (B)
(C) (D)
Fig. 8. WIF-1 transfection induces pigmentation in human melanocytes. WIF-1 inhibited
cell growth of human melanocytes. Human melanocytes were transfected with different
concentrations of WIF-1. The cell proliferation was measured at 5 days using the coulter
counter. Results were expressed as a percentage of proliferation to the respective controls
(A). Human melanocytes were transfected with different concentrations of WIF-1 for 5 days.
Melanin content was determinutesed by measuring the absorbance at 490 ㎚ (B). The cells
40
were incubated with 10 mM DOPA for 90 minutes and the absorbance was measured at 490
㎚ (C). Western blot analysis. EV, empty pcDNA3.1 vector; WIF-1, WIF-1 construct in HA
vector (D). (*P < 0.001 using one-way ANOVA. Data are means ± SD.)
Table. 5. Effects of WIF-1 transfection on proliferation, melanin contents and
tyrosinase activity of human melanocytes.
41
IV. DISCUSSION
This study presented for the first time that WIF-1 mRNA and protein are expressed in
human melanocytes. Also, this study clearly demonstrated that WIF-1 treatment or
transfection accelerated pigmentation of human melanocytes. The increase of pigmentation
was due to the stimulatory action of WIF-1 on dopa oxidase activity and MITF expression
which eventually led to the melanin biosynthesis. Wnt signaling is a major cell signal
transduction pathway and plays an important role in the proliferation and differentiation of
cells. Wnt-antagonists function as tumor suppressors and contribute to the pathogenesis of
several human malignancies (Ding et al., 2009). In the normal state, WIF-1 act as negative
regulators of Wnt signaling. Transfection with a WIF-1 gene construct had been reported to
result in significant tumor suppression in colorectal cancer cells (Taniguchi et al., 2005;
Yamaguchi et al., 2005) In this work, melanoma cell growth was suppressed with WIF-1.
It is generally known that inhibition of Wnt signaling pathway reduces pigmentation in
melanocytes. Therefore, the stimulatory effect of WIF-1 in melanocytes seems not to be
related to canonical Wnt pathway. WIF-1 may act as a stimulator of Wnt signaling pathway
in melanocytes. Further study is needed to investigate the exact role of WIF-1 in Wnt
signaling pathway in melanocytes.
42
V. CONCLUSION
1. WIF-1 mRNA and protein are expressed in normal human melanocytes, fibroblasts and
keratinocytes.
2. WIF-1 treatment and transfection induce pigmentation of cultured skin, B16 melanoma
cells and melanocytes.
3. WIF-1 treatment increased expression of MITF, and tyrosinase in B16 melanoma cells and
melanocytes.
In conclusion, this study suggests the regulatory role of the WIF-1 in melanogenesis of
human melanocytes.
43
REFERENCES
1. Aravind L, Koonin EV: A colipase fold in the carboxy-terminutesal domain of the
Wnt antagonists--the Dickkopfs. Curr Biol 8: R477-478, 1998
2. Batra S, Shi Y, Kuchenbecker KM, He B, Reguart N, Mikami I, You L, Xu Z, Lin
YC, Clement G, Jablons DM: Wnt inhibitory factor-1, a Wnt antagonist, is silenced
by promoter hypermethylation in malignant pleural mesothelioma. Biochem Biophys
Res Commun 342: 1228-1232, 2006
3. Behrens J, Lustig B: The Wnt connection to tumorigenesis. Int J Dev Biol 48: 477-
487, 2004
4. Bouwmeester T, Kim S, Sasai Y, Lu B, De Robertis EM: Cerberus is a head-inducing
secreted factor expressed in the anterior endoderm of Spemann's organizer. Nature
382: 595-601, 1996
5. Cadigan KM, Nusse R: Wnt signaling: a common theme in animal development.
Genes Dev 11: 3286-3305, 1997
6. Chien AJ, Conrad WH, Moon RT: A Wnt survival guide: from flies to human disease.
J Invest Dermatol 129: 1614-1627, 2009
44
7. Collavin L, Kirschner MW: The secreted Frizzled-related protein Sizzled functions
as a negative feedback regulator of extreme ventral mesoderm. Development 130:
805-816, 2003
8. Ding Z, Qian YB, Zhu LX, Xiong QR: Promoter methylation and mRNA expression
of DKK-3 and WIF-1 in hepatocellular carcinoma. World J Gastroenterol 15: 2595-
2601, 2009
9. Dorsky RI, Moon RT, Raible DW: Control of neural crest cell fate by the Wnt
signalling pathway. Nature 396: 370-373, 1998
10. Dunn KJ, Brady M, Ochsenbauer-Jambor C, Snyder S, Incao A, Pavan WJ: WNT1
and WNT3a promote expansion of melanocytes through distinct modes of action.
Pigment Cell Res 18: 167-180, 2005
11. Dunn KJ, Williams BO, Li Y, Pavan WJ: Neural crest-directed gene transfer
demonstrates Wnt1 role in melanocyte expansion and differentiation during mouse
development. Proc Natl Acad Sci U S A 97: 10050-10055, 2000
12. Glinka A, Wu W, Delius H, Monaghan AP, Blumenstock C, Niehrs C: Dickkopf-1 is
a member of a new family of secreted proteins and functions in head induction.
Nature 391: 357-362, 1998
45
13. Hsieh JC, Kodjabachian L, Rebbert ML, Rattner A, Smallwood PM, Samos CH,
Nusse R, Dawid IB, Nathans J: A new secreted protein that binds to Wnt proteins
and inhibits their activities. Nature 398: 431-436, 1999
14. Itoh K, Krupnik VE, Sokol SY: Axis determinutesation in Xenopus involves
biochemical interactions of axin, glycogen synthase kinase 3 and beta-catenin. Curr
Biol 8: 591-594, 1998
15. Jansen S, Kriegesmann B, Brenig B: Emulation of an ELISA reader and quantitative
image analysis using the computer program Digital-OD. Biotechniques 24: 998-1001,
1998
16. Jones SE, Jomary C: Secreted Frizzled-related proteins: searching for relationships
and patterns. Bioessays 24: 811-820, 2002
17. Kawano Y, Kypta R: Secreted antagonists of the Wnt signalling pathway. J Cell Sci
116: 2627-2634, 2003
18. Krupnik VE, Sharp JD, Jiang C, Robison K, Chickering TW, Amaravadi L, Brown
DE, Guyot D, Mays G, Leiby K, Chang B, Duong T, Goodearl AD, Gearing DP,
Sokol SY, McCarthy SA: Functional and structural diversity of the human Dickkopf
gene family. Gene 238: 301-313, 1999
46
19. LaBonne C, Bronner-Fraser M: Induction and patterning of the neural crest, a stem
cell-like precursor population. J Neurobiol 36: 175-189, 1998
20. Langan EA, Nie Z, Rhodes LE: Melanotropic peptides: more than just 'Barbie drugs'
and 'sun-tan jabs'? Br J Dermatol 163: 451-455, 2010
21. Prota G: Melanins, melanogenesis and melanocytes: looking at their functional
significance from the chemist's viewpoint. Pigment Cell Res 13: 283-293, 2000
22. Saitoh A, Hansen LA, Vogel JC, Udey MC: Characterization of Wnt gene expression
in murine skin: possible involvement of epidermis-derived Wnt-4 in cutaneous
epithelial-mesenchymal interactions. Exp Cell Res 243: 150-160, 1998
23. Sakai D, Tanaka Y, Endo Y, Osumi N, Okamoto H, Wakamatsu Y: Regulation of
Slug transcription in embryonic ectoderm by beta-catenin-Lef/Tcf and BMP-Smad
signaling. Dev Growth Differ 47: 471-482, 2005
24. Schmidt C, McGonnell I, Allen S, Patel K: The role of Wnt signalling in the
development of somites and neural crest. Adv Anat Embryol Cell Biol 195: 1-64,
2008
25. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R, Ben-Ze'ev
A: The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad
Sci U S A 96: 5522-5527, 1999
47
26. Taniguchi H, Yamamoto H, Hirata T, Miyamoto N, Oki M, Nosho K, Adachi Y,
Endo T, Imai K, Shinomura Y: Frequent epigenetic inactivation of Wnt inhibitory
factor-1 in human gastrointestinal cancers. Oncogene 24: 7946-7952, 2005
27. Tomita Y, Maeda K, Tagami H: Melanocyte-stimulating properties of arachidonic
acid metabolites: possible role in postinflammatory pigmentation. Pigment Cell Res
5: 357-361, 1992
28. Tsuboi T, Kondoh H, Hiratsuka J, Mishima Y: Enhanced melanogenesis induced by
tyrosinase gene-transfer increases boron-uptake and killing effect of boron neutron
capture therapy for amelanotic melanoma. Pigment Cell Res 11: 275-282, 1998
29. van Tilbeurgh H, Bezzine S, Cambillau C, Verger R, Carriere F: Colipase: structure
and interaction with pancreatic lipase. Biochim Biophys Acta 1441: 173-184, 1999
30. Veeman MT, Axelrod JD, Moon RT: A second canon. Functions and mechanisms of
beta-catenin-independent Wnt signaling. Dev Cell 5: 367-377, 2003
31. Yamaguchi Y, Hearing VJ, Itami S, Yoshikawa K, Katayama I: Mesenchymal-
epithelial interactions in the skin: aiminutesg for site-specific tissue regeneration. J
Dermatol Sci 40: 1-9, 2005
48
32. Yamaguchi Y, Passeron T, Hoashi T, Watabe H, Rouzaud F, Yasumoto K, Hara T,
Tohyama C, Katayama I, Miki T, Hearing VJ: Dickkopf 1 (DKK1) regulates skin
pigmentation and thickness by affecting Wnt/beta-catenin signaling in keratinocytes.
FASEB J 22: 1009-1020, 2008
49
- 국 요약 -
인체 라닌 포 라닌 에 한 WIF-1 효과
아주 학 학원 생명과학과
란
(지도 : 강 희 )
경: Wnt inhibitory factor (WIF)-1 Wnt antagonist 억 알 있다.
아직 지 WIF-1이 인체 라닌 포 색소 과 에 미 는 향에 한
연구는 없다.
목 : 인체 라닌 포에 WIF-1 WIF-1 색소 과 에 미 는
효과를 알아보고자 하 다.
법: WIF-1 면역조직 학염색, 면역 포 학염색, 특 단 질 검출 검
사 역 사 합연쇄 이용하여 알아 보았다. 포증식 쿨 계 를
사용하여 하 다. 색소 라닌 양, 티 시나아 단 질
하 다.
결과: 라닌 포에 WIF-1 mRNA 단 질 인 하 다. WIF-1
라닌 포 증식 억 하고 라닌양과 티 시나 증가 시켰다.
WIF-1에 한 색소 증가를 티 시나 MITF 증가에 한 것
나타났다.
50
결 : WIF-1 라닌 포에 다. WIF-1 라닌 포 색소 도한
다.
핵심어 : 라닌 포, 색소 과 , WIF-2, 색소 , Wnt 억 자
Recommended